MEDIQUELL Trademark

Trademark Overview


On Monday, October 31, 2022, a trademark application was filed for MEDIQUELL with the United States Patent and Trademark Office. The USPTO has given the MEDIQUELL trademark a serial number of 97656194. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 17, 2024. This trademark is owned by Venkor Corporation. The MEDIQUELL trademark is filed in the Pharmaceutical Products category with the following description:

Oral dosage formulations for use as pharmaceuticals, nutraceuticals, and dietary supplements, taking the form of liquids, syrups, beads, granules, solid tablets, chewable tablets, dissolvable tablets, confections, lozenges, and gum for treatment or prevention of diseases and conditions in the oral cavity, the nasal passages and sinuses, the throat, the respiratory system, the gastrointestinal tract, the endocrine system, the cardiovascular system, the lymphatic system, the nervous system, the skeletal system, the muscular system, the urinary system, or the reproductive system, including symptoms of viral or bacterial infections of the foregoing systems, namely, cough, nasal congestion, runny nose, post-nasal drip, chest congestion, fever, aches, pain, dyspepsia, diarrhea, heartburn, gastroesophageal reflux disease (GERD), and symptoms of autoimmune conditions and disorders, namely, allergies, diabetes, Crohn's disease, fibromyalgia, Addison disease, Celiac disease, and lactose intolera...
mediquell

General Information


Serial Number97656194
Word MarkMEDIQUELL
Filing DateMonday, October 31, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements


Goods and ServicesOral dosage formulations for use as pharmaceuticals, nutraceuticals, and dietary supplements, taking the form of liquids, syrups, beads, granules, solid tablets, chewable tablets, dissolvable tablets, confections, lozenges, and gum for treatment or prevention of diseases and conditions in the oral cavity, the nasal passages and sinuses, the throat, the respiratory system, the gastrointestinal tract, the endocrine system, the cardiovascular system, the lymphatic system, the nervous system, the skeletal system, the muscular system, the urinary system, or the reproductive system, including symptoms of viral or bacterial infections of the foregoing systems, namely, cough, nasal congestion, runny nose, post-nasal drip, chest congestion, fever, aches, pain, dyspepsia, diarrhea, heartburn, gastroesophageal reflux disease (GERD), and symptoms of autoimmune conditions and disorders, namely, allergies, diabetes, Crohn's disease, fibromyalgia, Addison disease, Celiac disease, and lactose intolerance

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVenkor Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHagerstown, MD 21740

Party NameVenkor Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHagerstown, MD 21740

Trademark Events


Event DateEvent Description
Thursday, November 3, 2022NEW APPLICATION ENTERED
Thursday, November 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 14, 2023ASSIGNED TO EXAMINER
Tuesday, August 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, June 17, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, November 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT